Skip to main content
The Globe and Mail
Get full access to globeandmail.com
Support quality journalism
Just $1.99 per week for the first 24weeks
Just $1.99 per week for the first 24weeks
The Globe and Mail
Support quality journalism
Get full access to globeandmail.com
Globe and Mail website displayed on various devices
Just$1.99
per week
for the first 24weeks

var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){console.log("scroll");var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))}pencilInit(".js-sub-pencil",!1);

Our roundup of Canadian small-caps of between $100-million and $2.5-billion in market capitalization making news and on the move today.

Slate Office REIT (SOT.UN-T) announced an agreement to sell 225 Duncan Mill Road in the Greater Toronto Area for a sale price of $27.3-million. The REIT said it expects to use the net proceeds to reduce debt.

“The disposition of 225 Duncan Mill Road is another example of the REIT’s ability to source and execute on transactions that generate meaningful returns for unitholders,” said Scott Antoniak, the REIT’s CEO. “This disposition will reduce leverage and create liquidity for new opportunities in the future.”

Story continues below advertisement

**

theScore, Inc. (SCR-X) reported record first quarter EBITDA of $1-million versus EBITDA of $500,000 for the same period a year ago. The company also reported record revenue of $9.5-million in the quarter ended Nov. 30 versus $8.4 million a year earlier. Net income was $163,000 versus a loss of $260,000 a year ago.

**

Points International Ltd. (PTS-T; PCOM-Q) reported preliminary financial results on Thursday, saying it expects gross profit growth to be at the upper half of its previously issued 2018 outlook, which had gross profit up 10-to-20 per cent from last year. It said adjusted EBITDA growth is also expected to be at the highest end of its outlook, which is up 30-to-40 per cent from 2017.

“These results were driven by continued execution of our three core growth drivers - closing new program relationships, expanding current partnerships through cross-selling new services and focusing on data-driven performance of in-market services," stated CEO Rob MacLean."

The company's fourth quarter and full year 2018 results will be reported on March 6.

**

Story continues below advertisement

The Flowr Corp. (FLWR-X) announced it received approval from Health Canada to open additional grow rooms at its Kelowna 1 cultivation facility. The company said it expects to begin growing in a portion of the newly approved rooms immediately.

“We’re building out our capacity as planned to ensure we can meet the growing demand for our products from our provincial partners and under our new medical cannabis supply agreement with Shoppers Drug Mart,” said Tom Flow, co-CEO of Flowr. “The shortage of premium adult-use cannabis we predicted has become a reality since last October and ramping up our facilities will provide much-needed, high-quality product to the market.”

**

Auxly Cannabis Group Inc. (XLY-X) announced it has signed a definitive agreement to acquire 46 per cent of 2368523 Ontario Limited (d/b/a) Curative Cannabis.

The company said it’s buying the stake in exchange for about 5 million common shares. Auxly also entered into a long-term cannabis purchase and sale agreement to fund the construction and development costs of Curative’s cannabis cultivation facility in Chatham-Kent, Ont., in exchange for the right to purchase 50 per cent of the cannabis products and cannabis trim produced at the facility at an offtake price equal to Curative’s direct cost of cultivation plus 10 per cent. Auxly will also receive a right of first refusal over any future expansion of the facility and/or the proposed construction of any new cannabis production facility, among other terms.

**

Story continues below advertisement

Westleaf Inc. (WL-X) announced it has exercised its option to acquire 100-per-cent of Canndara Canada Inc., a cannabis retail company. On Dec. 20, Westleaf purchased 21.4 per cent for $7.5- million and secured an option to acquire the rest for an aggregate purchase price of $48.4-million. It will pay for the deal by issuing about a million shares of Westleaf valued at $2.24 each.

"This acquisition will position Westleaf to become one of the largest premium cannabis retailers in Western Canada." said Scott Hurd, CEO of Westleaf.

**

ICC International Cannabis Corp. (WRLD.U-C) announced it has acquired an interest in Macedonian pharmaceutical manufacturer, Alkaloid AD Skopje, which it said it part of its Balkan Cannabis acquisition,

“International Cannabis’ stake in Alkaloid affords the company a dominant regional partner with over eight decades of pharmaceutical manufacturing experience," stated Eugene Beukman, CEO of International Cannabis.

**

Story continues below advertisement

Novagold Resources Inc. (NG-T) reported a net loss of US$6.1-million in its fourth quarter, compared to a net loss of US$10-million for the comparable period in 2017. “The decrease in net loss primarily resulted from lower equity losses from Donlin Gold due to the 2017 drilling program and lower permitting activity,” the company said in its MD&A document filed on Sedar.

Related topics

Report an error Editorial code of conduct
Tickers mentioned in this story
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies